Skip to main content
Annals of Pediatric Surgery
Download PDF

A scoping review on acute gastrointestinal surgical complications in immunocompromised pediatric patients

Annals of Pediatric Surgery volume 18, Article number: 52 (2022) Cite this article

Abstract

Background

Gastrointestinal complications are becoming increasingly more common and pose a significant risk on the health of children with compromised immunity caused by various etiologies such as chemotherapy and posttransplantation immunosuppression. We aim to review abdominal complications in immunocompromised children and their respective management.

Main body

This is a scoping review of the literature. PubMed, MEDLINE, Google Scholar, and Scopus libraries were searched for relevant articles. Extracted data included the etiologies of immunocompromised immunity, gastrointestinal and abdominal complications in immunocompromised children, diagnosis, and treatment of these pathologies. Examples of gastrointestinal complications in immunocompromised children include, but not limited to, neutropenic enterocolitis, acute appendicitis, bowel perforation, acalculous cholecystitis, and acute pancreatitis. Our literature review showed that bacterial and fungal infections are the major causes of exacerbation and mortality. The main cause of immunosuppression in children with neutropenic enterocolitis and acute pancreatitis is chemotherapy, and management of these pathologies using intravenous fluids, antibiotic therapy, and granulocyte-stimulating factors is the current standard of care. Surgical intervention is uncommon and reserved for complicated cases. That said, in acute appendicitis and bowel perforation, laparoscopy is the mainstay treatment. However, in systemic infections, nonsurgical interventions such as transfusion and bowel rest are the gold standard. As for acalculous cholecystitis, percutaneous cholecystectomy is superior to laparotomy and other surgical interventions.

Conclusion

Timely diagnosis and management of gastrointestinal complications in the immunocompromised children is key in reducing mortality and morbidity. Both surgical and nonsurgical interventions are needed and should be further studied in order to improve outcomes.

Background

Immunocompromised children are at an increased risk of developing life-threatening emergencies and acute gastrointestinal (GI) surgical complications such as pancreatitis, colitis, cholecystitis, viscus perforation, and typhlitis. The immunocompromised condition itself or the treatment regimens and medications that accompany the patient’s compromised immunity are the main predisposing factors. Identifying such risks and potential complications as soon as possible is crucial in limiting and preventing escalation in morbidity and mortality rates. In this scoping review, we focus on the published data on the clinical features and management options of the most commonly encountered acute GI surgical pathologies in the immunocompromised pediatric population.

Methodology

PubMed, MEDLINE, Scopus, and Google Scholar libraries were searched between the years 1989 and 2020 using each of the keywords “Immunocompromised host,” “Chemotherapy,” “Neoplasm,” “Malignancy,” “Congenital immunodeficiency,” “Transplant,” “Post-transplant,” “SCID,” “Primary Immunodeficiency Diseases” with each of “Neutropenic enterocolitis,” “Appendicitis,” “Bowel perforation,” “Cholecystitis,” “Pancreatitis,” and “Typhlitis.”

The results were independently screened by the authors for relevant articles. Selected articles focused on patients under 18 years of age and included case reports, case series, systematic reviews, and meta-analyses. Extracted data included the etiology behind the patients’ immunocompromised condition, the number of cases studied, and their acute surgical complications. Data on the diagnostic methods and treatment regimens for each condition were collected. Articles written only in English were selected.

Table 1 summarizes the published case reports/series of children who developed acute abdominal surgical emergencies in the context of compromised immunity.

Table 1 Recorded acute abdominal surgical emergencies in immunocompromised children
Full size table

Neutropenic enterocolitis or typhlitis

Neutropenic enterocolitis (NE), also known as typhlitis, is an inflammation of the cecum, colon, or small intestine [37]. Exposure to chemotherapy that induces mucositis and mucosal wall interruption and assists in bacterial translocation across the intestinal walls is hypothesized to be the main cause of this condition. Neutropenia exacerbates this bacterial spread following the weakened immune system’s response against the infection [38]. Invasive fungal infections also seem to play a role and have been shown to increase mortality and morbidity in patients with NE. Two cases have been reported where patients with simultaneous infection of invasive pulmonary aspergillosis and hepatosplenic candidiasis suffered major exacerbations during chemotherapy, despite optimal treatment with amphotericin B [33].

The most common symptoms seen in patients with NE include high fever and right-sided abdominal pain in the context of neutropenia [39]. Computed tomographic (CT) scan is recommended for documenting a mural wall thickness of more than 5 mm, but a definitive diagnosis of NE is established histologically in the presence of edema with mucosal ulceration and necrosis [40, 41]. In a case of a 13-year-old child with Fanconi anemia having severe neutropenia, abdominal ultrasound (US) showed a 1.18 cm thickening of the ascending colon and cecum. Early management and treatment in this patient resulted in favorable outcomes [35]. Similarly, in a study on 75 children with acute leukemia, 10 episodes of typhlitis (4.5%) were recorded in periods of severe neutropenia, with the cumulative risk being higher in patients with acute myeloid leukemia (AML) than acute lymphoblastic leukemia (ALL). However, despite the relatively low rate of typhlitis, mortality rate was 20% indicating that early detection and intervention are essential in decreasing mortality [42]. Similar results were reported of a group of 18 patients, 12 having ALL and 6 having AML, presenting for 20 episodes of NE. Mortality in this group reached 30% [36]. This demonstrates that chemotherapy and hematological malignancies both predispose to NE.

Management options include supportive, medical, and/or surgical therapy. In the absence of severe complications such as peritonitis, bleeding, or perforation, bowel rest and intravenous fluids along with broad-spectrum antibiotics targeting anaerobes are recommended [40, 43]. Other measures include antifungals targeting Candida and medications that help restore neutrophil counts [44]. Granulocyte colony-stimulating factor was shown to expedite neutrophil recovery on some occasions. In cases where the severe aforementioned complications were present, surgery was required [40].

Acute appendicitis

Acute appendicitis is the major causative pathology responsible for abdominal surgery in the pediatric population. It usually occurs as a result of luminal obstruction from a variety of causes that include a fecalith, mucosal inflammation, and lymphoid hyperplasia. The obstruction is then followed by appendiceal inflammation that can progress to transmural inflammation, ischemia, and infarction [45]. Cases of appendicitis are rarely reported in immunocompromised patients due to decreased lymphoid aggregates in this subset of patients [46].

Patients with acute appendicitis usually present with abdominal pain that later migrates to the right lower quadrant. The pain is associated with nausea, vomiting, low-grade fever, and mild leukocytosis. In immunocompromised patients, the absence of leukocytosis is a prominent feature. As for diagnosis, imaging, specifically CT scans or abdominal US scans, is the gold standard [47, 48].

Concerning the treatment of appendicitis, appendectomy remains the mainstay of treatment. Historically, it started in the 1800s with the conventional method of an incision in the right lower quadrant and was later followed in the 1990s with advancements through the introduction of laparoscopy [49]. As a result, laparoscopic appendectomy is currently the gold standard treatment for acute appendicitis. In the case of two pediatric patients with acute leukemia presenting for fungal appendicitis, laparoscopic appendectomy prevented fungal dissemination and led to successful treatment [7].

However, there is still no consensus on whether the medical or the surgical interventional method should be used as the mainstay treatment in uncomplicated appendicitis in the immunocompromised. In a hemodynamically stable patient, first-line treatment with antibiotics and interventional radiology consultation and/or growth factor support should be considered [50]. The most commonly used antibiotics include meropenem or piperacillin-tazobactam and are administered intravenously for 24 to 48 h. They are followed by approximately 7 days of amoxicillin-clavulanate or ciprofloxacin and metronidazole [51]. In patients with systemic infections, transfusion and bowel rest, along with the use of granulocyte colony-stimulating factors, are common nonoperative treatments [52].

It follows that various bacterial and few fungal infections can present as acute appendicitis in immunocompromised hosts. In a case of a 17-year-old human immunodeficiency virus (HIV)-positive patient, cryptosporidiosis presented as acute appendicitis, causing major life-threatening complications [3]. Three patients undergoing chemotherapy, two having candida and one Aspergillus infections, presented for acute appendicitis and underwent appendectomy. Only one of the three patients received curative treatment and survived [6]. Similarly, a 13-year-old leukemic child with aspergillosis developed acute appendicitis. After being admitted for chemotherapy intensification, the child soon developed abdominal pain, intermittent fever, and tenderness in the periumbilical region. Appendectomy for this patient soon followed, and his chemotherapy regime was continued [4]. Human cytomegalovirus (HCMV) viral infections are a very rare cause of acute appendicitis in immunocompromised patients. However, one study on 14 patients showed an association between HCMV and acute appendicitis, whereby cells double positive for early antigens and IL-6/IL-8 were prominent in 9 of 14 (64.4%) of appendicitis patients. HCMV late antigen was also found in 6 of 14 (42.9%) of the patients, and latent HCMV was present in as high as 11 of 14 (78.6%) of the patients as confirmed by in situ hybridization and HCMV IgG antibodies [53].

Another example of acute appendicitis was reported in a 6-year-old child with Wilms’ tumor on chemotherapy. At first, the child had low-grade fever, persistent vomiting, and nonspecific intermittent “crampy” sensations at the level of the abdomen with no abdominal tenderness or rebound tenderness at McBurney’s point. He was admitted with the suspected diagnosis of sepsis, and soon, his abdominal pain increased and became persistent with right lower quadrant guarding and tenderness at McBurney’s point. He also underwent appendectomy followed by nephrectomy for his Wilms’ tumor and continued chemotherapy as planned [2].

When dealing with severe cases of acute appendicitis, early intervention and treatment should be initiated to ensure favorable clinical courses. This was demonstrated in the case of an 11-year-old patient with AML who was found to have Aspergillus appendicitis and had undergone urgent appendectomy. Prolonged antifungal therapy was given until remission from ALL was established [8]. Similarly, a 4-year-old patient with ALL and having mucormycotic appendicitis was able to recover his neutrophil count after surgery and prolonged antifungal therapy with monitored serum Posaconazole [5].

Bowel perforation

Bowel perforation is defined as the discontinuity of the intestines and is the byproduct of a multitude of disease processes. In premature infants, the major cause is necrotizing enterocolitis, while in children and teenagers, it is usually due to appendicitis. However, in adults, the causes can vary widely [54].

Physical examination can be of importance in diagnosing bowel perforation. Almost all patients with bowel perforation present with abdominal pain, vomiting, nausea, decreased bowel function, and fever. Moreover, a detailed history of previous endoscopic retrograde cholangiopancreatography (ERCP) and colonoscopy should be noted if present [55, 56]. Vital signs assessment is essential for evaluating the presence of a systemic inflammatory response syndrome or sepsis [54]. On abdominal examination, abdominal rigidity and absent or hypoactive bowel sounds indicate bowel perforation [57]. We can distinguish perforation from obstruction through the presence of signs such as palpable peristalsis characteristic of obstruction and collection of a mass, gas, or fluid [58]. Other typical findings suggestive of obstruction include increased tympany and high-pitched bowel sounds [59]. Abdominal examination is also important to rule out acute surgical abdomen, whereby rebound tenderness and involuntary guarding might suggest a diagnosis of appendicitis or cholecystitis and require surgical intervention [60].

Several modalities are available for the evaluation of bowel perforation. A plain abdominal X-ray is cost-efficient and easy to perform and can detect signs of pneumoperitoneum. However, a CT scan of the abdomen and pelvis remains the gold standard in diagnosing the etiology behind the perforation [61]. In a case of a child with ALL having a perforated appendix and ileum, CT scan helped uncover extraluminal air that was otherwise overlooked on plain abdominal film [1]. A similar finding can be seen in Fig. 1.

Fig. 1
figure 1

Showing an example of intraoperative laparoscopic findings of bowel (cecal) inflammation and perforation in a patient with ALL on chemotherapy who presented with severe abdominal pain and findings of free air in the abdomen on CT scan

Full size image

In the pediatric population, bowel perforation is considered an uncommon entity, due to the vague pathogenesis underlying it, an event that makes its diagnosis misleading and eventually delayed [62]. Fungal infections such as intestinal mucormycosis can be responsible for bowel perforation. Although rare, it is a critical condition that requires intensive care. This is demonstrated in a report of three children presenting with mucormycosis infection post bowel obstruction or perforation, who suffered major exacerbations including death [10]. Two children who presented for ALL were found to have intestinal mucormycosis, and only one survived [16]. Another interesting case was that of a malnourished child who presented with peritonitis and was intraoperatively found to have three perforations that showed characteristic hyphae under histopathological examination of their edges that confirmed the presence of gastrointestinal mucormycosis [13]. Other cases that involve infectious agents and perforation include intestinal tuberculosis. A case of a 17-year-old male with Down syndrome demonstrates how obstructive and perforated ileal tuberculosis caused multiple tuberculosis live abscesses [12]. Transplant pediatric patients are also an important target population when it comes to intestinal perforation. Posttransplant lymphoproliferative disorder (PTLD) is a serious complication and often develops after an Epstein-Barr virus infection. Of 14 patients having PTLD, 8 patients developed abdominal involvement, and 4 of them died of PTLD complications, one of which is bowel perforations. Similarly, this was seen in the case of a 3-year-old child who developed EBV and ulcerations in the sigmoid colon as a result of PTLD [15]. An interesting but rare case of an 11-year old with bowel perforation after peritoneal dialysis catheter removal posttransplantation reflects the complications that arise in the time period between transplantation and catheter removal [17].

Surgical resection of the involved segment is the standard of care in isolated bowel perforations. Platelet and neutrophil counts play a role in the timing of the surgery and the duration of recovery [16]. Historically, laparotomy was the main surgical procedure in the treatment of bowel perforation; however, with the emerging improvements in the field of medicine, laparoscopic intervention is one of the practical options used in identifying and treating the perforation [63]. Creating an intestinal stoma is also a possible surgical method. In a case study on 18 patients suffering from non-Hodgkin’s lymphoma and undergoing 19 stomas, 9 children survived. Despite suffering many postoperative complications, stoma creation did not diminish their chances of survival [11].

Acalculous cholecystitis

Acalculous cholecystitis was first described in 1844 [64] and is defined as the acute inflammation of the gallbladder in the absence of gallstones [65]. It occurs due to stasis and an increase in the intraluminal pressure, which also leads to wall ischemia. The stasis is responsible for the colonization of bacteria and thus inflammation. The pressure buildup which causes ischemia can lead to sepsis due to gangrenous changes and perforation [66, 67].

Patients presenting with acalculous cholecystitis usually have right upper quadrant pain, positive murphy sign, food intolerance, nausea, and bloating. Diagnostic evaluation usually includes an US or a cholescintigraphy nuclear scan (HIDA). Another imaging method sometimes used is CT scan [68, 69].

Although acalculous cholecystitis is very uncommon in the pediatric population, it represents the major cause of cholecystitis, reaching up to 50–70% of all cholecystitis patients [65, 70]. This increase in diagnosed cases may be attributed to the improvement in echographic imaging, whereby imaging has shown acute acalculous cholecystitis (AAC) presenting with wall thickening greater than or equal to 3 cm, biliary sludge, gallbladder distension (> 5 cm), and wall edema [71]. A retrospective review of immunocompromised children between 2006 and 2013 who underwent percutaneous cholecystostomy (PC) highlights the association between acute acalculous cholecystitis and immunocompromised states in the pediatric population. Ten children aged between 10 months and 15 years and 8 months were included in the study. Six of the immunocompromised children received bone marrow transplant for leukemia (5 children) or severe combined immunodeficiency (SCID) (1 child). The remaining four children had leukemia (2 children), SCID (1 child), and lymphoma (1 child) [18]. Similarly, Rose et al. examined the cholecystectomy specimens from a pediatric institution over a 24-month period and recorded 3 children (2 children with hemoglobinopathies and 1 with mononucleosis) with eosinophilic cytoplasmic inclusions on the gallbladder [19].

Acalculous cholecystitis in the pediatric population is generally secondary to infection [72], trauma, intra-abdominal inflammatory disorders, and postoperative complication [73]. Immunocompromised children on the other hand can also present with AAC; however, the aforementioned subgroup is deemed as a poor surgical candidate. Thus, PC is more likely to be the preferred procedure in this group of patients. Moreover, in some cases, PC might obviate the need for future cholecystectomy [18]. In a PC, a thin hollow flexible tube is placed in the gallbladder to drain bile outside the body, under imaging guidance. In this process, inflammation and infection are reduced [74]. This procedure is said to be superior to laparoscopic or surgical cholecystectomy, for it decreases the chances of sepsis and shortens hospital stay [18].

Acute pancreatitis

Acute pancreatitis (AP) involves the inflammation of the pancreatic parenchyma. The diagnosis is usually made on clinical grounds. Patients usually present with epigastric pain that is accompanied by nausea and anorexia. The type of pain varies depending on the etiology of the inflammation. When biliary obstruction is the cause, the pain is usually sharp and radiates to the back. On the other hand, when toxic or metabolic exposure is the cause, the pain is usually generalized [75]. When evaluating acute pancreatitis, one should look for physical symptoms that are consistent with acute pancreatitis, lab values showing serum amylase and lipase levels more than three times their upper limits, and US or CT scan to evaluate for any pancreatic damage [76]. Recent reports have shown an increase in the number of patients with pancreatitis in the pediatric population [77]. Several factors have been shown to play a role, as will be discussed below.

To start with, children with cancer receiving certain types of medications have been shown to be at a higher risk of developing pancreatitis. L-Asparaginase, which is used in the treatment of ALL and some non-Hodgkin lymphomas (NHL), is one of these main drugs. Thirty-one (11%) of 275 patients receiving L-asparaginase suffered from abdominal pain, nausea, and vomiting [78]. An example of this can be seen in Fig. 2. No genetic factors have been shown to explain the association between this drug and AP [79]. Corticosteroids, such as dexamethasone and prednisone that are used in induction therapy in ALL pediatric patients, also play a role. Teuffel et al. conducted a meta-analysis on the topic and stated that the risk ratio for AP stimulated by dexamethasone, and prednisone was 3.78% [80]. These findings were further supported by the study conducted by Bai et al. that showed that corticosteroids and valproic acid were the main drugs responsible for the development of pancreatitis in the pediatric population [81]. The trimethoprim/sulfamethoxazole (TMP/SMX) treatment has also been hypothesized to play a role. It is generally used in patients undergoing chemotherapy as prophylaxis against Pneumocystis jirovecii infection. However, the TMP/SMX combination has been shown to cause pancreatitis in adults more than in children, with this notion believed to be dose dependent. Other drugs, usually used in stem cell transplantation such as cyclosporine, tacrolimus, cidofovir, foscarnet, and ganciclovir, have also been shown to cause pancreatitis [77]. This was seen in a case report of a 9-year-old boy with chronic granulomatous disease (CGD) who underwent a nonmyeloablative-matched sibling bone marrow transplant and received tacrolimus and mycophenolate mofetil posttransplant. The child developed acute pancreatitis 19 days after the transplant [28].

Fig. 2
figure 2

Showing a CT scan of an 18-year-old patient with ALL who presented with severe epigastric pain

Full size image

In addition, hematopoietic stem cell transplantation (HSCT) itself can be a cause of pancreatitis in children. This was shown in a study conducted by Wherlin et al. that stated that 3.5% of 202 children who were treated with HSCT developed pancreatitis [24]. Similarly, a case of a 16-year-old female with acute B lymphoblastic leukemia (ALL-B) who received HSCT and developed acute pancreatitis 24 days after transplant supports the above notion [32]. Acute pancreatitis is also associated with organ and bone marrow transplantation. Between January 2001 and December 2004, Bateman et al. reported 5 children who received bone marrow transplant and developed acute pancreatitis, with 4 of them also having adenoviral infections [29]. Concerning organ transplantation, acute pancreatitis developed in a child with cystic fibrosis and Candida albicans infection post-lung transplantation [31] in a child 12 days after liver transplantation in 2002 [26], in 26 children between January 1986 and December 1999 also after liver transplantation [27], and in a 5-year-old girl after renal transplantation [30].

Other causes that have been suggested to cause pancreatitis include acquired infections in children such as HIV. Korayni et al. reported that in a children’s hospital over the course of 6 years, 10 out of 42 children (23.8%) infected with HIV developed pancreatitis [25]. Similar findings were reported in a study by Miller et al., where over a 6-year period, 9 (17%) of 53 pediatric patients infected with acquired immunodeficiency syndrome (AIDS) developed pancreatitis [23].

Regarding the management of AP, it is important to replenish fluids with crystalloids in the first 24 h. It is also essential to monitor the pulmonary, cardiac, and renal functions in the first 48 h. Furthermore, enteral nutrition should be administered as soon as it is tolerated [82]. Endoscopic and surgical approaches in the management of children with AP are uncommon [83]; however, in chronic pancreatitis, endoscopic procedures may be advantageous in the presence of a detectable stricture or pancreatic duct obstruction [84, 85]. On the other hand, surgical procedures that include decompression of dilated ducts or resection of strictures can also be of value in the treatment of chronic pancreatitis [86].

Conclusion

The immunocompromised pediatric population is particularly susceptible to acute abdominal complications that require pertinent diagnosis and treatment. Imaging modalities such as ultrasonography (US) and computed tomography (CT) are useful for the diagnosis of neutropenic enterocolitis, appendicitis, bowel perforation, acute pancreatitis, and acalculous cholecystitis. Histologic evaluation, pancreatic enzymes, and HIDA scan are essential in the cases of neutropenic enterocolitis, acute pancreatitis, and acalculous cholecystitis, respectively. Treatment options vary widely among these conditions and include supportive hydration, broad-spectrum antibiotics, and antifungal medications.

Availability of data and materials

PubMed, MEDLINE, Scopus, and Google Scholar libraries were searched between the years 1989 and 2020 using each of the keywords “Immunocompromised host,” “Chemotherapy,” “Neoplasm,” “Malignancy,” “Congenital immunodeficiency,” “Transplant,” “Post-transplant,” “SCID,” “Primary Immunodeficiency Diseases” with each of “Neutropenic enterocolitis,” “Appendicitis,” “Bowel perforation,” “Cholecystitis,” “Pancreatitis,” and “Typhlitis.” The selected articles focused on patients under 18 years of age and included case reports, case series, systematic reviews, and meta-analyses. Extracted data included the etiology behind the patients’ immunocompromised condition, in addition to their acute surgical complications. Only articles written in the English language were selected.

Abbreviations

ALL:

Acute lymphocytic leukemia

HIV:

Human immunodeficiency virus

AML:

Acute myeloid leukemia

BMT:

Bone marrow transplant

SCID:

Severe combined immunodeficiency disorder

PID:

Primary immunodeficiency disorder

HSCT:

Hematopoietic stem cell transplantation

CT:

Computed tomography

US:

Ultrasound

GI:

Gastrointestinal

NE:

Neutropenic enterocolitis

IBD:

Inflammatory bowel disease

PTLD:

Posttransplant lymphoproliferative

PC:

Percutaneous cholecystostomy

HIDA:

Hepatobiliary iminodiacetic acid

AP:

Acute pancreatitis

NHL:

Non-Hodgkin lymphomas

TMP/SMX:

Trimethoprim/sulfamethoxazole

CGD:

Chronic granulomatous disease

HCMV:

Human cytomegalovirus

ERCP:

Endoscopic retrograde cholangiopancreatography

AIDS:

Acquired immunodeficiency syndrome

References

  1. Gilad E, Paret G, Katz M, Vardi A, Kennet G, Barzilay Z. Plain radiography for diagnosis of gastrointestinal perforation in immune-compromised children—is it enough? Med Pediatr Oncol. 1995;25(6):470–2.

    Article  CAS  PubMed  Google Scholar 

  2. Velez MC, Athale UH, Loe W Jr, Warrier R. Acute perforative appendicitis during preoperative chemotherapy for Wilms tumor. Pediatr Hematol Oncol. 2003;20(2):147–50.

    Article  CAS  PubMed  Google Scholar 

  3. Buch K, Nguyen S, Divino CM, Weber K, Morotti RA. Cryptosporidiosis presenting as acute appendicitis: a case report. Am Surg. 2005;71(6):537–8.

    Article  PubMed  Google Scholar 

  4. Park BH, Suh JH, Choi HJ, Cha HJ, Nam CW, Kim YM. Acute appendicitis associated with aspergillosis in a leukemia patient: a case report. Korean J Pathol. 2010;44(3):330–2.

    Article  Google Scholar 

  5. Lüer S, Berger S, Diepold M, Duppenthaler A, von Gunten M, Mühlethaler K, et al. Treatment of intestinal and hepatic mucormycosis in an immunocompromized child. Pediatr Blood Cancer. 2009;52(7):872–4.

    Article  PubMed  Google Scholar 

  6. Larbcharoensub N, Boonsakan P, Kanoksil W, Wattanatranon D, Phongkitkarun S, Molagool S, et al. Fungal appendicitis: a case series and review of the literature. Southeast Asian J Trop Med Public Health. 2013;44(4):681.

    PubMed  Google Scholar 

  7. Carlini V, Calcaterra V, Decembrino N, Rubert L, Pasqua N, Novario M, et al. Fungal appendicitis in immunocompromised children. Indications and contraindications for laparoscopic appendectomy: a report on 2 successful cases. J Pediatr Hematol Oncol. 2016;38(7):581–4.

    Article  PubMed  Google Scholar 

  8. Yada Y, Koga Y, Ono H, Motomura Y, Esumi G, Kohashi K, et al. Acute isolated Aspergillus appendicitis in pediatric leukemia. J Infect Chemother. 2020;26(11):1229–31.

    Article  CAS  PubMed  Google Scholar 

  9. Yoshida N, Takahashi Y, Mori M, Saitou K, Yokota S, Mathuyama S, et al. A child case of down’s syndrome with intestinal tuberculosis and tuberculous pleuritis. Kansenshogaku zasshi J Jpn Assoc Infectious Diseases. 1989;63(12):1333–7.

    CAS  Google Scholar 

  10. Vadeboncoeur C, Walton J, Raisen J, Soucy P, Lau H, Rubin S. Gastrointestinal mucormycosis causing an acute abdomen in the immunocompromised pediatric patient—three cases. J Pediatr Surg. 1994;29(9):1248–9.

    Article  CAS  PubMed  Google Scholar 

  11. Rokhsar S, Harrison EA, Shaul DB, Phillips JD. Intestinal stoma complications in immunocompromised children. J Pediatr Surg. 1999;34(12):1757–61.

    Article  CAS  PubMed  Google Scholar 

  12. Polat KY, Aydinli B, Yilmaz O, Aslan S, Gursan N, Ozturk G, et al. Intestinal tuberculosis and secondary liver abscess. Mt Sinai J Med. 2006;73(6):887–90.

    PubMed  Google Scholar 

  13. Choudhury M, Kahkashan E, Choudhury SR. Neonatal gastrointestinal mucormycosis–a case report. Trop Gastroenterol. 2007;28(2):81–2.

    PubMed  Google Scholar 

  14. Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, et al. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality. J Pediatr Surg. 2008;43(12):2174–7.

    Article  PubMed  Google Scholar 

  15. Kutsch E, Kreiger P, Consolini D, Furuya KN. Colonic perforation after rituximab treatment for posttransplant lymphoproliferative disorder. J Pediatr Gastroenterol Nutr. 2013;56(6):e41.

    Article  PubMed  Google Scholar 

  16. Radhakrishnan N, Yadav SP, Oberoi J, Kulshreshta R, Bhalla S, Sachdeva A. Intestinal mucormycosis: a rare entity in pediatric oncology. Pediatr Hematol Oncol. 2013;30(3):178–83.

    Article  PubMed  Google Scholar 

  17. Maxted AP, Davies B, Colliver D, Williams A, Lunn A. Peritoneal dialysis catheter removal post-transplant—a rare case of delayed bowel perforation. Perit Dial Int. 2017;37(6):650–1.

    Article  PubMed  Google Scholar 

  18. Schaefer CM, Towbin RB, Aria DJ, Kaye RD. Safety and effectiveness of percutaneous cholecystostomy in critically ill children who are immune compromised. Pediatr Radiol. 2016;46(7):1040–5.

    Article  PubMed  Google Scholar 

  19. Rose GS, Arnold CA, Badizadegan K, Carter CM, Conces MR, Kahwash SB, et al. Cytoplasmic fibrillar aggregates in gallbladder epithelium are a frequent mimic of Cystoisospora in pediatric cholecystectomy specimens. Arch Pathol Lab Med. 2019;143(10):1259–64.

    Article  CAS  PubMed  Google Scholar 

  20. Lee JH, Park HY, Choe YH, Lee SK, Il LS. The development of eosinophilic colitis after liver transplantation in children. Pediatr Transplant. 2007;11(5):518–23.

    Article  CAS  PubMed  Google Scholar 

  21. Fernandes MA, Braun HJ, Evason K, Rhee S, Perito ER. De novo inflammatory bowel disease after pediatric kidney or liver transplant. Pediatr Transplant. 2017;21(1):e12835.

    Article  Google Scholar 

  22. Akkelle BS, Tutar E, Volkan B, Sengul OK, Ozen A, Celikel CA, et al. Gastrointestinal manifestations in children with primary immunodeficiencies: single center: 12 years experience. Dig Dis. 2019;37(1):45–52.

    Article  PubMed  Google Scholar 

  23. Miller TL, Winter HS, Luginbuhl LM, Orav EJ, Mclntosh K. Pancreatitis in pediatric human immunodeficiency virus infection. J Pediatr. 1992;120(2):223–7.

    Article  CAS  PubMed  Google Scholar 

  24. Werlin S, Casper J, Antonson D, Calabro C. Pancreatitis associated with bone marrow transplantation in children. Bone Marrow Transplant. 1992;10(1):65–9.

    CAS  PubMed  Google Scholar 

  25. Koranyi K, Brady M, Stock K, Lucas P, Nahata M. Pancreatitis in children infected with human immunodeficiency virus. Pediatr AIDS HIV Infect. 1996;7(4):261–5.

    CAS  PubMed  Google Scholar 

  26. Carter BA, Karpen SJ, Quiros-Tejeira RE, Chang I-f, Clark BS, Demmler GJ, et al. Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation. 2002;74(7):1050–2.

    Article  CAS  PubMed  Google Scholar 

  27. Eghtesad B, Reyes JD, Ashrafi M, Arzate J, Osorio G, Fung JJ, et al. Pancreatitis after liver transplantation in children: a single-center experience. Transplantation. 2003;75(2):190–3.

    Article  PubMed  Google Scholar 

  28. Sastry J, Young S, Shaw P. Acute pancreatitis due to tacrolimus in a case of allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33(8):867–8.

    Article  CAS  PubMed  Google Scholar 

  29. Bateman C, Kesson A, Shaw P. Pancreatitis and adenoviral infection in children after blood and marrow transplantation. Bone Marrow Transplant. 2006;38(12):807–11.

    Article  CAS  PubMed  Google Scholar 

  30. Cho MH, Hong EH, Lee HS, Ko CW. Recurrent pancreatitis after renal transplantation in a child. Pediatr Transplant. 2008;12(5):593–6.

    Article  PubMed  Google Scholar 

  31. Hammer MM, Zhang L, Stoll JM, Sheybani EF. Candida albicans pancreatitis in a child with cystic fibrosis post lung transplantation. Pediatr Radiol. 2016;46(4):575–8.

    Article  PubMed  Google Scholar 

  32. Qi C, Feng Y, Lu H, Chen L, Li J, Qiu H, et al. Acute pancreatitis developed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Int J Clin Exp Med. 2019;12(8):10973–7.

    Google Scholar 

  33. Avci Z, Alioglu B, Anuk D, Ozbek OY, Azap OK, Ozbek N. Double invasive fungal infection and typhlitis in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2008;25(2):99–106.

    Article  PubMed  Google Scholar 

  34. Haut C. Typhilitis in the pediatric patient. J Infus Nurs. 2008;31(5):270–7.

    Article  PubMed  Google Scholar 

  35. Tinsa F, Necib N, Guesmi M, Bousnina O, Douira W, Bousetta K, et al. Fanconi anemia complicated by neutropenic enterocolitis. Tunis Med. 2008;86(11):1011–3.

    PubMed  Google Scholar 

  36. User IR, Akbayram S, Özokutan BH. Clinical presentation, prognostic factors, and outcome in neutropenic enteropathy of childhood leukemia. J Pediatr Hematol Oncol. 2018;40(3):216–20.

    Article  PubMed  Google Scholar 

  37. Portugal R, Nucci M. Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review. Expert Rev Hematol. 2017;10(2):169–74.

    Article  CAS  PubMed  Google Scholar 

  38. Bertozzi G, Maiese A, Passaro G, Tosoni A, Mirijello A, Simone SD, et al. Neutropenic enterocolitis and sepsis: towards the definition of a pathologic profile. Medicina. 2021;57(6):638.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Li K, Zheng S, Dong K, Gao Y, Wang H, Liu G, et al. Diagnosis and outcome of neutropenic enterocolitis: experience in a single tertiary pediatric surgical center in China. Pediatr Surg Int. 2011;27(11):1191–5.

    Article  PubMed  Google Scholar 

  40. Xia R, Zhang X. Neutropenic enterocolitis: a clinico-pathological review. World J Gastrointest Pathophysiol. 2019;10(3):36.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Aina YTI, Emordi VC, Osagie OT. Neutropaenic enterocolitis: a medical/surgical oncological dilemma. Afr J Paediatr Surg. 2021;18(3):171.

    Google Scholar 

  42. Altınel E, Yarali N, Isık P, Bay A, Kara A, Tunc B. Typhlitis in acute childhood leukemia. Med Princ Pract. 2012;21(1):36–9.

    Article  PubMed  Google Scholar 

  43. Sundell N, Boström H, Edenholm M, Abrahamsson J. Management of neutropenic enterocolitis in children with cancer. Acta Paediatr. 2012;101(3):308–12.

    Article  PubMed  Google Scholar 

  44. Castagnola E, Ruberto E, Guarino A. Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000. World J Gastroenterol. 2016;22(25):5853.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Stringer MD. Acute appendicitis. J Paediatr Child Health. 2017;53(11):1071–6.

    Article  PubMed  Google Scholar 

  46. Scott-Conner C, Fabrega A. Gastrointestinal problems in the immunocompromised host. Surg Endosc. 1996;10(10):959–64.

    Article  CAS  PubMed  Google Scholar 

  47. Petroianu A. Diagnosis of acute appendicitis. Int J Surg. 2012;10(3):115–9.

    Article  PubMed  Google Scholar 

  48. Coccolini F, Improta M, Sartelli M, Rasa K, Sawyer R, Coimbra R, et al. Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines. World J Emerg Surg. 2021;16(1):1–21.

    Article  Google Scholar 

  49. Masoomi H, Nguyen NT, Dolich MO, Mills S, Carmichael JC, Stamos MJ. Laparoscopic appendectomy trends and outcomes in the United States: data from the Nationwide Inpatient Sample (NIS), 2004–2011. Am Surg. 2014;80(10):1074–7.

    Article  PubMed  Google Scholar 

  50. White MG, Morgan RB, Drazer MW, Eng OS. Gastrointestinal surgical emergencies in the neutropenic immunocompromised patient. J Gastrointest Surg. 2021;25(12):1–7.

    Article  Google Scholar 

  51. Pudela C, Lancaster S, McGahren E, Petersen WC. Appendicitis in neutropenic pediatric oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2020;42(8):e835–8.

    Article  PubMed  Google Scholar 

  52. Scarpa AA, Hery G, Petit A, Brethon B, Jimenez I, Gandemer V, et al. Appendicitis in a neutropenic patient: a multicentric retrospective study. J Pediatr Hematol Oncol. 2017;39(5):365–9.

    Article  PubMed  Google Scholar 

  53. Dzabic M, Boström L, Rahbar A. High prevalence of an active cytomegalovirus infection in the appendix of immunocompetent patients with acute appendicitis. Inflamm Bowel Dis. 2008;14(2):236–41.

    Article  PubMed  Google Scholar 

  54. Hafner J, Tuma F, Hoilat GJ, Marar O. Intestinal perforation. StatPearls. Treasure Island (FL): StatPearls [Internet] 2021.

  55. Bill JG, Smith Z, Brancheck J, Elsner J, Hobbs P, Lang GD, et al. The importance of early recognition in management of ERCP-related perforations. Surg Endosc. 2018;32(12):4841–9.

    Article  PubMed  Google Scholar 

  56. Wang H, Li A, Shi X, Xu X, Yu E. Diagnosis and treatment of iatrogenic colonoscopic perforation. Zhonghua wei chang wai ke za zhi. 2018;21(6):660–5.

    PubMed  Google Scholar 

  57. Albanese CT, Meza MP, Gardner MJ, Smith SD, Rowe MI, Lynch JM. Is computed tomography a useful adjunct to the clinical examination for the diagnosis of pediatric gastrointestinal perforation from blunt abdominal trauma in children? J Trauma Acute Care Surg. 1996;40(3):417–21.

    Article  CAS  Google Scholar 

  58. Balachandran B, Singhi S, Lal S. Emergency management of acute abdomen in children. Indian J Pediatr. 2013;80(3):226–34.

    Article  PubMed  Google Scholar 

  59. Jackson P, Raiji MT. Evaluation and mangement of intestinal obstruction. Am Fam Physician. 2011;83(2):159–65.

    PubMed  Google Scholar 

  60. Leung AK, Sigalet DL. Acute abdominal pain in children. Am Fam Physician. 2003;67(11):2321–6.

    PubMed  Google Scholar 

  61. Paolantonio P, Rengo M, Ferrari R, Laghi A. Multidetector CT in emergency radiology: acute and generalized non-traumatic abdominal pain. Br J Radiol. 2016;89(1061):20150859.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Gupta R, Singh D, Kumar R. Intestinal perforation in children-a clinico-pathologic evaluation of 67 cases: 1451. Official journal of the American College of Gastroenterology| ACG 2011;106:S555.

  63. Siragusa G, Gelarda E, Epifanio E, Geraci F, Geraci G. Video laparoscopy in abdominal emergencies. Minerva Chir. 1999;54(4):199–204.

    CAS  PubMed  Google Scholar 

  64. Savoca PE, Longo WE, Zucker KA, McMillen MM, Modlin IM. The increasing prevalence of acalculous cholecystitis in outpatients. Results of a 7-year study. Ann Surg. 1990;211(4):433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Poddighe D, Sazonov V. Acute acalculous cholecystitis in children. World J Gastroenterol. 2018;24(43):4870.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Yi DY, Chang EJ, Kim JY, Lee EH, Yang HR. Age, predisposing diseases, and ultrasonographic findings in determining clinical outcome of acute acalculous inflammatory gallbladder diseases in children. J Korean Med Sci. 2016;31(10):1617–23.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Le Bail B. Pathology of gallbladder and extrahepatic bile ducts. Case 1 Alcalculous gangrenous cholecystitis. Annales de pathologie. 2014;34:271–8.

    PubMed  Google Scholar 

  68. Thampy R, Khan A, Zaki IH, Wei W, Korivi BR, Staerkel G, et al. Acute acalculous cholecystitis in hospitalized patients with hematologic malignancies and prognostic importance of gallbladder ultrasound findings. J Ultrasound Med. 2019;38(1):51–61.

    Article  PubMed  Google Scholar 

  69. Noh SY, Gwon DI, Ko G-Y, Yoon H-K, Sung K-B. Role of percutaneous cholecystostomy for acute acalculous cholecystitis: clinical outcomes of 271 patients. Eur Radiol. 2018;28(4):1449–55.

    Article  PubMed  Google Scholar 

  70. Aguilera-Alonso D, Medina EML, Del Rosal T, Arrieta JV, Escosa-García L, García-Hortelano M. Acalculous cholecystitis in a pediatric patient with Plasmodium falciparum infection: a case report and literature review. Pediatr Infect Dis J. 2018;37(2):e43–5.

    Article  PubMed  Google Scholar 

  71. Barie PS, Eachempati SR. Acute acalculous cholecystitis. Curr Gastroenterol Rep. 2003;5(4):302–9.

    Article  PubMed  Google Scholar 

  72. Prashanth GP, Angadi BH, Joshi SN, Bagalkot PS, Maralihalli MB. Unusual cause of abdominal pain in pediatric emergency medicine. Pediatr Emerg Care. 2012;28(6):560–1.

    Article  PubMed  Google Scholar 

  73. Shihabuddin B, Sivitz A. Acute acalculous cholecystitis in a 10-year-old girl with cystic fibrosis. Pediatr Emerg Care. 2013;29(1):117–21.

    Article  PubMed  Google Scholar 

  74. Akhan O, Akıncı D, Özmen MN. Percutaneous cholecystostomy. Eur J Radiol. 2002;43(3):229–36.

    Article  PubMed  Google Scholar 

  75. Gapp J, Chandra S. Acute pancreatitis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.

  76. Copyright © 2021, StatPearls Publishing LLC.; 2021.

  77. Tietz NW. Support of the diagnosis of pancreatitis by enzyme tests—old problems, new techniques. Clin Chim Acta. 1997;257(1):85–98.

    Article  CAS  PubMed  Google Scholar 

  78. Stefanović M, Jazbec J, Lindgren F, Bulajić M, Löhr M. Acute pancreatitis as a complication of childhood cancer treatment. Cancer Med. 2016;5(5):827–36.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Wolthers BO, Frandsen TL, Baruchel A, Attarbaschi A, Barzilai S, Colombini A, et al. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno toxicity working group study. Lancet Oncol. 2017;18(9):1238–48.

    Article  CAS  PubMed  Google Scholar 

  80. Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C, et al. Clinical and genetic risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia. J Clin Oncol. 2016;34(18):2133.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Teuffel O, Kuster S, Hunger S, Conter V, Hitzler J, Ethier M, et al. Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia. 2011;25(8):1232–8.

    Article  CAS  PubMed  Google Scholar 

  82. Bai HX, Ma MH, Orabi AI, Park A, Latif SU, Bhandari V, et al. Novel characterization of drug-associated pancreatitis in children. J Pediatr Gastroenterol Nutr. 2011;53(4):423.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Abu-El-Haija M, Kumar S, Quiros JA, Balakrishnan K, Barth B, Bitton S, et al. The management of acute pancreatitis in the pediatric population: a clinical report from the NASPGHAN Pancreas Committee. J Pediatr Gastroenterol Nutr. 2018;66(1):159.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Pohl JF, Uc A. Pediatric pancreatitis. Curr Opin Gastroenterol. 2015;31(5):380.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Cremer M, Devière J, Delhaye M, Baize M, Vandermeeren A. Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy. 1991;23(03):171–6.

    Article  CAS  PubMed  Google Scholar 

  86. Ponchon T, Bory RM, Hedelius F, Roubein LD, Paliard P, Napoleon B, et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc. 1995;42(5):452–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

No funds were received in support of this study.

Author information

Authors and Affiliations

  1. Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon

    Tarek Bou Dargham, Mohamad Bahij Moumneh, Christine Atallah & Ahmad Zaghal

Authors
  1. Tarek Bou Dargham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamad Bahij Moumneh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine Atallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmad Zaghal
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TBD, MBM, and CA contributed to writing and editing the article. AZ is the surgeon who supervised in writing and finalizing the article. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Ahmad Zaghal.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dargham, T.B., Moumneh, M.B., Atallah, C. et al. A scoping review on acute gastrointestinal surgical complications in immunocompromised pediatric patients. Ann Pediatr Surg 18, 52 (2022). https://doi.org/10.1186/s43159-022-00183-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43159-022-00183-2

Keywords